Effect of long-term progestin treatment on endometrial vasculature in normal cycling mice
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the long-term effects of progestin treatment on the endometrial vasculature of cycling mice.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The aim of this study was to develop a mouse model to investigate the effects of long-term progestin-only exposure on endometrial vascular structure. Normal cycling mice received Silastic implants containing either medroxyprogesterone acetate (MPA) or levonorgestrel (LNG) and were dissected after 1, 3 or 6 weeks. Endometrial vascular density increased significantly within 1 week of MPA (482 +/- 40.2 vessels/mm2) or LNG (440 +/- 26.5 vessels/mm2) treatment compared with normal cycling mice (293 +/- 10.5 vessels/mm2). MPA increased stromal cell density within 1 week of treatment (13813 +/- 1450 cells/mm2) compared with normal cycling mice (8256 +/- 928 cells/mm2). However, although LNG significantly increased stromal cell density overall, the increase did not reach significance within the individual weeks examined. There was no significant change in the ratio of vascular to stromal cell density among treated and normal cycling mice. Epithelial cell height significantly decreased within 1 week of LNG (17.6 +/- 1.3 microm) treatment compared with normal cycling mice (23.5 +/- 1.3 microm); epithelial cell height also decreased within 1 week of MPA treatment (16.6 +/- 2.1 microm), although this did not reach statistical significance. VEGF immunostaining increased significantly in luminal epithelium after MPA or LNG treatment, and in glandular epithelium after LNG treatment. These observations are similar to those reported in human endometrium, suggesting that this mouse model may facilitate further investigations into breakthrough bleeding due to long-term progestin use.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- A functional model for progestogen-induced breakthrough bleeding via openalex
- A longitudinal study of changes in endometrial microvascular density in norplant® implant users via openalex
- Disturbances of endometrial bleeding with hormone replacement therapy via openalex
- Human uterine vascular structures in normal and diseased states via openalex
- Mechanisms and regulations of endometrial angiogenesis via openalex
- The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium via openalex
- The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium via openalex
- W2146845375 via openalex
- W2154785421 via openalex
- W2262444131 via openalex
- W2418754503 via openalex
- W3113142429 via openalex
- W1967781227 via openalex
- W6716698088 via openalex
- W1975917043 via openalex
- W1991467549 via openalex
- W2019175232 via openalex
- W2112292608 via openalex
- W2141810620 via openalex
- W2142155939 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-11T06:32:28.951138+00:00
License: CC0
· commercial use OK